immune

(redirected from Hydrops fetalis)
Also found in: Dictionary, Thesaurus, Medical, Legal, Wikipedia.
Related to Hydrops fetalis: erythroblastosis fetalis

immune

Med protected against a specific disease by inoculation or as the result of innate or acquired resistance

immune

[i′myün]
(immunology)
Safe from attack; protected against a disease by an innate or an acquired immunity.
Pertaining to or conferring immunity.
References in periodicals archive ?
Hydrops fetalis resulting from Hb Bart's disease and molecular characterization of Hb H disease in Turkey have been reported (5); however, the prevalence and distribution of deletional alpha-thalassemia, which is responsible for Hb Bart's disease, is not known.
The reasons that investigations were focused on storage diseases from the beginning in this patient included presence of a similar history of death of a sibling which supported autosomal recessive transmission and exclusion of chromosomal, infectious and cardiac causes which could lead to non-immune hydrops fetalis in the prenatal follow-up.
If sole CCAM and hydrops fetalis are present, extrauteral "intrapartum" surgical treatment is performed after the 32nd gestational week and thoracoamniotic shunt or open fetal surgery are recommended before the 32nd gestational week.
SEA]), and both GM03037 and GM03433 were initiated from fibroblasts obtained from patients with HbBarts hydrops fetalis ([sup.
Hemophagocytic lymphohistiocytosis presenting with nonimmune hydrops fetalis.
Some neonates have died with infiltration of blasts in various organs or were born with hydrops fetalis.
Fetal anomalies that may indicate delivery by C-section include monoamniotic or conjoined twins because of cord entanglement, hydrocephalus, cystic hygroma, sacrococcygeal teratomas, congenital heart block, hydrops fetalis, and skeletal dysplasia.
In utero infections result in severe anemia and hydrops fetalis.
Lepore] Thalassemia Major Clinical Hemoglobinopathy Syndrome Significance [Alpha]-Thalassemia Hydrops fetalis Fetal death, difficult pregnancy [Beta]-Thalassemia [Beta]-Thalassemia major Transfusion dependent Hemoglobin E [Beta]-Thalassemia major Transfusion dependent Hemoglobin Lepore [Beta]-Thalassemia major Transfusion dependent
The license provides Meridian with exclusive and global rights to utilize the patented technology to develop, manufacture and market the Parvovirus B19 Vaccine for Fifth Disease, Transient Aplastic Crisis (TAC), and Hydrops Fetalis.
The diseases manifested with PV-B19 are erythema infectiosum, which is common in children, hydrops fetalis, transient pure red cell aplasia in patients with chronic hemolytic anemia, arthralgia - mostly observed in women, and chronic pure red cell aplasia in immunocompromised individuals.